PerCP/Cyanine5.5 anti-mouse IFN-γ Antibody

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells or 5 ?l per 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

ELISA^1-4,11,14 or ELISPOT⁵ Detection: The biotinylated XMG1.2 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified R4-6A2 antibody (Cat. No. 505702/505706) as the capture antibody and recombinant mouse IFN-? (Cat. No. 575309) as the standard.
ELISA or ELISPOT Capture: The purified XMG1.2 antibody is useful as a capture antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated R4-6A2 antibody (Cat. No. 505704) as the detection antibody and recombinant mouse IFN-? (Cat. No. 575309) as the standard. The LEAF? purified antibody is suggested for ELISPOT capture (Cat. No. 505812).
Flow Cytometry^7,8,12,13,16: The fluorochrome-labeled XMG1.2 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-?-producing cells within mixed cell populations.
Neutralization^1-3,9,10: The XMG1.2 antibody can neutralize the bioactivity of natural or recombinant IFN-?. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for neutralization of mouse IFN-? bioactivity in vivo and in vitro (Cat. No. 505812). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 505834) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin <0.01 EU/?g).
Additional reported applications (for the relevant formats) include: Western blotting, immunohistochemical staining of frozen tissue sections^6,22,23, and immunocytochemistry.
Note: For testing mouse IFN-? in serum, plasma or supernatant, BioLegend's ELISA Max? Sets (Cat. No. 430801 to 430806) are specially developed and recommended.

BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.

1. Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA, Neut)
2. Sander B, et al. 1993. J. Immunol. Meth. 166:201. (ELISA, Neut)
3. Abrams J, et al. 1995. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.20. (ELISA, Neut)
4. Yang X, et al. 1993. J. Immunoassay 14:129. (ELISA)
5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.19. (ELISPOT)
6. Sander B, et al. 1991. Immunol. Rev. 119:65. (IHC)
7. Ferrick D, et al. 1995. Nature 373:255. (FC)
8. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
9. Peterson KE, et al. 2000. J. Virol. 74:5363. (Neut)
10. DeKrey GK, et al. 1998. Infect. Immun. 66:827. (Neut)
11. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
12. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
13. Lee JW, et al. 2006. Nature Immunol. 8:181. (FC) PubMed
14. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
15. Montfort M, et al.2004. J. Immunol. 173:4084. PubMed
16. Haring JS, et al. 2008. J. Immunol. 180:2855. (FC) PubMed
17. Jordan JM, et al. 2008. Infect Immun. 76:3717. PubMed
18. Tonkin DR, et al. 2008. J. Immunol. 181:4516. PubMed
19. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
20. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
21. Mykkanen OT, et al. 2014. PLoS One. 9:114790. PubMed
22. Yokogawa M, et al. 2013. Mol. Carcinog. 52:760. (IHC)
23. Mottram PL, et al. 1998. J Immunol. 161:602. (IHC)

1. Lee Y, et al. 2020. J Innate Immun. 1:. PubMed
2. Chen H, et al. 2005. J Immunol. 175:591. PubMed
3. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
4. Wu T, et al. 2021. Mol Ther Oncolytics. 23:420. PubMed
5. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
6. Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
7. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
8. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
9. Volkov A, et al. 2013. PLoS One. 8:60565. PubMed
10. Luo Z, et al. 2020. Front Immunol. 0.883333333. PubMed
11. Li B, et al. 2015. Sci Rep. 5: 14793. PubMed
12. Braun F, et al. 2015. PLoS One. 10: 0135444. PubMed
13. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
14. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
15. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
16. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
17. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
18. Coe D, et al. 2022. JCI Insight. 7:. PubMed
19. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
20. Carty S, et al. 2014. PLoS One. 9:106659. PubMed
21. Ye X, et al. 2021. Cancer Biol Med. Online ahead of print. PubMed
22. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
23. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
24. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
25. Benci JL et al. 2019. Cell. 178(4):933-948 . PubMed
26. He Y, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.04.001. PubMed
27. Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
28. Li X, et al. 2016. MBio. 7: 02232-15. PubMed
29. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
30. Jeon Y, et al. 2015. PLoS One. 10: e0139845. PubMed
31. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
32. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
33. Burger ML, et al. 2021. Cell. 184:4996. PubMed
34. Wu R, et al. 2020. J Immunother Cancer. 8:00. PubMed
35. Ikeda T, et al. 2014. PLoS One. 9:115198. PubMed
36. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151.